Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Operating Margin: 2010-2018

Historic Operating Margin for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -2,788.89%.

  • EyePoint Pharmaceuticals' Operating Margin fell 122889.00% to -2,788.89% in Q3 2018 from the same period last year, while for Sep 2018 it was -1,517.36%, marking a year-over-year decrease of 128987.00%. This contributed to the annual value of -887.34% for FY2018, which is 64094.00% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Operating Margin stood at -2,788.89% for Q3 2018, which was down 103.85% from -1,368.11% recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Operating Margin ranged from a high of 82.15% in Q3 2014 and a low of -5,808.00% during Q4 2017.
  • For the 3-year period, EyePoint Pharmaceuticals' Operating Margin averaged around -1,824.66%, with its median value being -1,560.00% (2017).
  • Over the last 5 years, EyePoint Pharmaceuticals' Operating Margin had its largest YoY gain of 124,836bps in 2017, and its largest YoY loss of 580,643bps in 2017.
  • EyePoint Pharmaceuticals' Operating Margin (Quarterly) stood at -790.02% in 2014, then tumbled by 20,580bps to -995.82% in 2015, then surged by 99,424bps to -1.57% in 2016, then plummeted by 580,643bps to -5,808.00% in 2017, then tumbled by 122,889bps to -2,788.89% in 2018.
  • Its Operating Margin stands at -2,788.89% for Q3 2018, versus -1,368.11% for Q2 2018 and -504.09% for Q1 2018.